Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$910K Sell
5,837
-296
-5% -$46.9K 0.05% 227
2025
Q1
$1.01M Buy
6,133
+795
+15% +$132K 0.06% 201
2024
Q4
$870K Sell
5,338
-760
-12% -$136K 0.05% 217
2024
Q3
$1.19M Sell
6,098
-34
-0.6% -$6.26K 0.08% 174
2024
Q2
$1.06M Sell
6,132
-356
-5% -$59.2K 0.07% 171
2024
Q1
$1.1M Buy
6,488
+1,297
+25% +$243K 0.08% 168
2023
Q4
$1.02M Buy
5,191
+311
+6% +$55.1K 0.08% 160
2023
Q3
$849K Buy
4,880
+401
+9% +$72.8K 0.08% 167
2023
Q2
$771K Buy
4,479
+1,016
+29% +$176K 0.08% 158
2023
Q1
$576K Buy
3,463
+1,140
+49% +$187K 0.06% 186
2022
Q4
$340K Sell
2,323
-191
-8% -$28.3K 0.04% 254
2022
Q3
$373K Buy
2,514
+512
+26% +$85.6K 0.05% 221
2022
Q2
$344K Buy
2,002
+95
+5% +$16.4K 0.04% 230
2022
Q1
$360K Sell
1,907
-520
-21% -$103K 0.04% 248
2021
Q4
$592K Buy
2,427
+982
+68% +$215K 0.06% 177
2021
Q3
$281K Buy
+1,445
New +$292K 0.03% 224

Other funds holding ZTS

Graypoint LLC's ZTS Position: Q2 2025 in Review

Graypoint LLC reduced its Zoetis (ZTS) stake by 4.8% in Q2 2025, selling an estimated $46.9K and leaving 5,837 shares worth $910K. The position accounts for 0.05% of the portfolio, ranked #227.

Graypoint LLC first reported a position in ZTS in Q3 2021 and has held it in 16 quarters since. The position peaked at $1.19M in Q3 2024. 1,870 funds tracked by Wall St. Rank hold ZTS as of Q2 2025.

  • Graypoint LLC held 5,837 shares of Zoetis worth $910K as of Q2 2025.
  • Graypoint LLC sold 296 Zoetis shares in Q2 2025, an estimated $46.9K.
  • Zoetis made up 0.05% of Graypoint LLC's portfolio in Q2 2025, its #227 holding.
  • Graypoint LLC first reported a position in Zoetis in Q3 2021 and has held it in 16 quarters since.
  • Graypoint LLC's Zoetis position peaked at $1.19M in Q3 2024.
  • 1,870 funds tracked by Wall St. Rank held Zoetis as of Q2 2025.

Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.